The Patentability of Biomolecules and Online Bioinformatics
Author Information
Author(s): Anton Hutter
Primary Institution: Appleyard Lees, Chartered and European Patent Attorneys
Hypothesis
Does the use of online bioinformatics compromise the novelty of biomolecule sequences for patent applications?
Conclusion
Using online bioinformatics tools can jeopardize the novelty of biomolecule sequences, potentially invalidating patent applications.
Supporting Evidence
- Researchers are concerned that sharing biomolecule sequences online may destroy their novelty.
- 70-80% of new sequences submitted to EMBL are held confidential for a period.
- The EPO provides search facilities that maintain confidentiality and do not risk novelty.
Takeaway
When scientists share their gene sequences online, it might make it harder for them to get patents on those sequences later.
Methodology
The article reviews the implications of online bioinformatics on the patentability of biomolecules, analyzing various methods of data sharing and their risks.
Potential Biases
Potential bias may arise from the author's affiliation with a patent attorney firm.
Limitations
The article does not provide empirical data or case studies to support its claims.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website